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We recently reported purification, determination of the nucleotide sequence, and cloning of a 60-nucleotide
RNA (I-RNA) from the yeast Saccharomyces cerevisiae which preferentially blocked cap-independent, internal
ribosome entry site (IRES)-mediated translation programmed by the poliovirus (PV) 5* untranslated region
(UTR). The I-RNA appeared to inhibit IRES-mediated translation by virtue of its ability to bind a 52-kDa
polypeptide which interacts with the 5* UTR of viral RNA. We demonstrate here that the HeLa 52-kDa
I-RNA-binding protein is immunologically identical to human La autoantigen. Moreover, I-RNA-mediated
inhibition of PV 5* UTR-dependent translation in cell extracts can be reversed by exogenous addition of
purified La protein. By using I-RNAs with defined deletions, we have identified sequences of I-RNA required
for inhibition of internal initiation of translation. Two smaller fragments of I-RNA (16 and 25 nucleotides)
inhibited PV UTR-mediated translation from both monocistronic and bicistronic RNAs. When transfected into
HeLa cells, these derivatives of I-RNA inhibited translation of PV RNA. A comparison of protein binding by
active and inactive I-RNA mutants demonstrates that in addition to the La protein, three other polypeptides
with apparent molecular masses of 80, 70, and 37 kDa may influence the translation-inhibitory activity of
I-RNA.
The single-stranded, positive-sense RNA genome of polio-
virus (PV), a member of the Picornaviridae family, translates in
a unique cap-independent manner in the cytoplasm of infected
cells. The translation of the viral RNA genome produces a
polyprotein (;250 kDa) which is cleaved by virus-encoded
proteases into structural and nonstructural proteins (28). In-
terestingly, PV RNA translates inside infected cells in an en-
vironment where cap-dependent translation of the majority of
cellular capped mRNAs is impaired, and thus the viral RNA
must translate by an alternative mechanism (49, 55). The viral
RNA is naturally uncapped but instead has a small virus-
encoded protein, Vpg, covalently linked to its 59 end. The
unusually long (;750 nucleotides [nt]) 59 untranslated region
(UTR) of viral RNA is highly structured and contains multiple
AUG triplets (1, 40, 48). In sharp contrast to the scanning
mechanism of the cap-dependent translation of eukaryotic
mRNAs, the 59 UTR of PV RNA can mediate the binding of
ribosome internally to a sequence between nt 130 and 630. This
sequence element has been termed ribosome landing pad or
the internal ribosome entry site (IRES) (41, 52). Many other
picornaviruses, such as human rhinovirus, encephalomyocardi-
tis virus, foot-and-mouth disease virus (FMDV), coxsackievi-
rus, Theiler’s murine encephalomyelitis virus, and hepatitis A
virus, have been shown to utilize this novel mechanism (2, 3, 6,
7, 17, 24, 25, 27, 32). In addition to picornaviruses, many other
viruses, such as hepatitis C virus, murine leukemia virus, in-
fectious bronchitis virus, duck hepatitis B virus, pestivirus, and
plant potyviruses, are believed to utilize internal initiation of
translation for synthesis of one or more gene products (4, 10,
15, 29, 30, 44, 46, 53). Cellular mRNAs encoding immunoglob-
ulin heavy-chain-binding protein, Drosophila antennapedia
protein, and the mouse androgen receptor also use IRES-
mediated initiation of protein synthesis (21, 33, 39).
The IRES sequences of different picornaviruses are con-
served and can be exchanged (24, 27). When the IRES se-
quence is placed upstream of a reporter gene or as an inter-
cistronic spacer in a bicistronic construct, it can direct cap-
independent translation both in vitro and in vivo (3, 25). The
presence of a polypyrimidine tract near the 39 border of the
IRES and an appropriately spaced downstream AUG at nt 586
is common to all picornaviruses and is believed to be important
for proper functioning of the IRES element (24, 26, 43). The
precise mechanism of internal initiation of translation is un-
clear. Studies from several laboratories suggest the importance
of specific interactions of cellular proteins with various ele-
ments containing secondary structures within the 59UTR. One
of the two extensively studied proteins is a 52-kDa polypeptide
(p52) which binds to stem loop G (nt 559 to 624) of the 59UTR
of the poliovirus RNA (35). p52 has recently been identified as
the La autoantigen (36), which causes an autoimmune re-
sponse in patients with systemic lupus erythematosus and
Sjo¨gren’s syndrome (51). The human La autoantigen binds to
the 39-terminal sequences of almost all nascent polymerase III
transcripts. Although not absolutely necessary, La has been
reported to stimulate transcription by RNA polymerase III in
vitro (18, 34). Cell extracts immunodepleted of La antibodies
cannot promote cap-independent translation, and exogenous
addition of purified La protein can correct aberrant translation
products of poliovirus RNA in a reticulocyte lysate in which
p52 is limiting (36, 50). The other cellular protein, p57, has
been shown to interact with three distinct domains within the
59 UTR of PV (22, 31, 54). The p57 appears to be identical to
the polypyrimidine tract-binding protein (PTB). Immu-
nodepletion of PTB from HeLa cell extracts prevents transla-
tion of PV RNA, although exogenous addition of purified PTB* Corresponding author.
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failed to restore translation (22). Interestingly, recent studies
using mutants having deletions of different stem-loop domains
of the PV 59UTR demonstrated that interaction neither of p57
with stem-loop F-G nor of p52 with stem-loop G is required for
internal ribosome binding (19, 20, 42). These studies, however,
do not rule out the possibility that these polypeptides interact
with other regions of the viral UTR. Thus, the functional
significance of La and PTB in IRES-mediated translation is not
clearly established, and possible involvement of other RNA-
protein and/or protein-protein interactions in IRES-mediated
translation is being explored by many laboratories. In a recent
report, RNA-protein interaction with stem-loop E (nt 234 to
440) has been shown to be important for PV translation (5). A
40-kDa protein interacts directly with PV RNA, whereas two
other proteins with molecular masses of 39 and 42 kDa joins
the complex through protein-protein interaction (5). Addition-
ally, it has been demonstrated that stem-loop G also harbors a
binding site for a 39-kDa protein whereas a longer RNA com-
prising stem-loops F and G interacts with a 36-kDa protein
(20). A number of other cellular proteins, such as p50, p54, and
p48, have been demonstrated to interact specifically with de-
fined regions of the 59UTR of the PV RNA, but the functional
significance of these interactions is unknown (16, 38). Very
recently, it has been demonstrated that one of the major ini-
tiation factors, eIF4B, interacts directly with the IRES element
of FMDV (37).
Recently we reported purification, determination of the nu-
cleotide sequence, and cloning of a small (60-nt) RNA (I-
RNA) molecule from the yeast Saccharomyces cerevisiae that
was isolated on the basis of its ability to selectively block
translation of PV RNA both in vivo and in vitro (13). I-RNA
derived from the clone inhibited PV IRES-mediated transla-
tion, did not inhibit cap-dependent translation from capped
monocistronic RNAs, and selectively blocked internal initia-
tion of translation from a bicistronic mRNA containing IRES
sequences of PV RNA (13). UV cross-linking studies demon-
strated that I-RNA specifically bound cellular proteins be-
lieved to be required for IRES-mediated translation. Specifi-
cally purified I-RNA competed with viral RNA elements
within the 59 UTR which bind a cellular protein with an ap-
proximate molecular mass of 52 kDa. Finally, when transfected
into HeLa cells, I-RNA efficiently inhibited replication of PV
RNA by inhibiting translation of input viral RNA.
In this report, we demonstrate that the HeLa 52-kDa I-
RNA-binding protein is immunologically identical to the La
autoantigen. Moreover, I-RNA-mediated inhibition of trans-
lation programmed by the PV 59 UTR in cell extracts can be
rescued by exogenous addition of purified La protein. By using
various deleted I-RNAs, we have identified smaller segments
of I-RNA which efficiently inhibit internal initiation of trans-
lation from both monocistronic and bicistronic RNA con-
structs. Finally, when transfected into HeLa cells, these trun-
cated derivatives of I-RNA inhibited translation of PV RNA.
A comparison of cellular protein binding by truncated I-RNAs
which inhibit IRES-mediated translation with those which do
not suggests a possible mode of action of I-RNA-mediated
inhibition of viral translation.
MATERIALS AND METHODS
Cells and viruses. HeLa cells were grown in suspension culture in S minimum
essential medium (GIBCO Laboratories) supplemented with 6% newborn calf
serum. HeLa monolayers were grown in tissue culture flask in minimal essential
medium supplemented with 5% fetal bovine serum. PV RNA (type 1 Mahoney)
was prepared as described previously (14).
HeLa S10 extract and RSW preparation. HeLa cell extracts were prepared as
previously described (12, 13, 47). The ribosomal salt wash (RSW) from HeLa
cells was prepared as described by Brown and Ehrenfeld (8), with some modi-
fications. Cultures of HeLa cells (4 3 105 cells per ml) were harvested by
centrifugation, washed three times with cold isotonic buffer (35 mM N-2-hy-
droxyethylpiperazine-N9-2-ethanesulfonic acid [HEPES; pH 7.5], 146 mM NaCl,
11 mM glucose), resuspended in a 23 packed-cell volume of lysis buffer (10 mM
KCl, 1.5 mM magnesium acetate, 20 mM HEPES [pH 7.4], 1 mM dithiothreitol
[DTT]), and then incubated on ice for 10 min for swelling. Cells were disrupted
at 08C with 50 strokes in a type B Dounce homogenizer. After disruption, extracts
were centrifuged for 15 min at 10,000 rpm at 48C in a Sorvall SS34 rotor to
remove nuclei and mitochondrial fractions. The supernatant (S10 extract) was
centrifuged at 50,000 rpm for 2 h at 48C in a Beckman Ti60 rotor. The ribosome
pellet was resuspended at a concentration of approximately 250 A260/ml in lysis
buffer with gentle shaking on an ice bath. The KCl concentration was then
adjusted to 500 mM, and the solution was stirred for 30 min on an ice bath. The
resulting solution was centrifuged for 2 h at 50,000 rpm at 48C. The supernatant
(salt wash) was then subjected to 0 to 70% ammonium sulfate precipitation. The
pellet containing initiation factors was dissolved in a low volume of dialysis buffer
(without glycerol) and then subjected to overnight dialysis at 48C against dialysis
buffer (5 mM Tris [pH 7.5], 100 mM KCl, 0.05 mM EDTA, 1 mM DTT, 5%
glycerol). The dialysate was then centrifuged at 10,000 rpm for 10 min at 48C, and
the supernatant was aliquoted in small volumes into several prechilled tubes and
stored at 2708C.
In vitro transcription. Different mRNAs were transcribed in vitro by using the
T7 or SP6 promoter from linear plasmids with T7 or SP6 RNA polymerase,
respectively. The pSDIR clone (13) was linearized with restriction enzyme
HindIII; the linear fragment was gel purified and then transcribed with T7 RNA
polymerase to generate I-RNA (sense transcript). Plasmids p2CAT and
pG3CAT (12, 13) were linearized with BamHI and transcribed with SP6 RNA
polymerase. The PV type 2 IRES containing bicistronic construct pGem CAT/
P2-59/luc (generous gift from N. Sonenberg) was linearized with XhoI, and the
runoff capped transcript was generated with T7 RNA polymerase. The nonspe-
cific RNA was synthesized from pGem 3Z vector DNA (Promega), linearized
with HindIII, and transcribed by T7 RNA polymerase.
Construction of I-RNA deletion mutants. I-RNA deletion mutants were gen-
erated by in vitro transcription with T7 RNA polymerase from oligonucleotide
templates. Different lengths of oligonucleotides were synthesized (Biosynthesis
Inc.); each began with a T7 promoter adapter sequence followed by various
lengths from different regions of I-RNA sequences. Oligodeoxyribonucleotide
templates were mixed with equimolar amounts of the 17-mer T7 primer oligo-
nucleotide in 0.1 M NaCl and annealed by heating at 1008C for 5 min followed
by slow cooling to room temperature. The nucleotide positions of the different
I-RNA deletion mutants are shown in Fig. 3. The nucleotide sequence for the
yeast I-RNA has been published elsewhere (reference 13 and EMBL database
library accession number X76506).
In vitro translation. In vitro translation in HeLa cell extracts was performed
essentially as described elsewhere (13, 47). Approximately 2 mg of each mRNA
was used with 80 mg of HeLa cell extract in the presence of 25 mCi of [35S]me-
thionine (800 Ci/mmol; Amersham) and 40 U of RNasin (Promega) in a 25-ml
reaction volume. To study the effects of I-RNA-induced inhibition and La pro-
tein-induced reversal of inhibition of in vitro translation of the chloramphenicol
acetyltransferase (CAT) gene from p2CAT mRNA, PV-infected HeLa extracts
were preincubated on ice for 30 min with I-RNA alone (1.5 mg) and together
with either purified La (1.5 mg) or bovine serum albumin (BSA; 1.5 mg) before
addition to the reaction mixture.
Mobility shift electrophoresis. Fifty micrograms of HeLa S10 extract or 10 mg
of HeLa RSW was preincubated at 308C for 10 min with 4 mg of poly(dI-dC)
(Pharmacia) in a 15-ml reaction mixture containing 5 mM HEPES (pH 7.6), 25
mM KCl, 2 mM MgCl2, 2 mM DTT, 0.1 mM EDTA, 1.5 mM ATP, 2 mM GTP,
and 3.8% glycerol. For competition experiments, 100-fold molar excesses of
unlabeled competitor RNAs were added to the reaction mixtures, which were
then incubated for 10 min at 308C. Finally, 5 to 10 fmol of labeled RNA probe
was added to the reaction mixtures, and incubation was continued for another 20
min at 308C. Three microliters of gel loading dye was added to each reaction
mixture to a final concentration of 5% glycerol and 0.02% each bromophenol
blue and xylene cyanol. For supershift assays, the S10 extract was preincubated
with either 2.5 ml of nonimmune human serum or 2.5 ml of immune human
serum against La protein on ice for 10 min, the appropriate 32P-labeled RNA
probe was then added to the reaction mixture, and incubation was continued for
another 20 min on ice. The RNA protein complexes were then analyzed on a 4%
polyacrylamide gel (39:1 ratio of acrylamide to bisacrylamide) containing 5%
glycerol in 0.53 Tris-borate-EDTA.
UV-induced cross-linking and immunoprecipitation. 32P-labeled RNA-pro-
tein complexes generated as described above were irradiated with a UV lamp
(multiband UV; 254/366 nm; model UGL; 25 UVP Inc.) at a distance of 2 to 3
cm for 15 min in a microtiter plate. Unbound RNAs were then digested with a
mixture of 20 mg of RNase A and 20 U of RNase T1 at 378C for 15 min. For the
immunoprecipitation of labeled complexes, 2 to 5 ml of either nonimmune
human serum or immune human serum from a patient with lupus disease (La
antibody [9]) was added, and the mixture was kept on ice for 2 h in the presence
of 200 ml of 13 radioimmunoprecipitation assay buffer (5 mM Tris [pH 7.9], 150
mM NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate [SDS], 1% sodium
deoxycholate). Five milligrams of protein A-Sepharose was then added to each
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reaction tube; the tubes were rocked in a cold room for 1 h and then centrifuged
at 12,000 rpm for 5 min at 48C. Beads were washed with 13 radioimmunopre-
cipitation assay buffer three times to reduce nonspecific binding. Finally, resus-
pended beads in 13 SDS-gel loading dye (50 mM Tris [pH 6.8], 100 mM DTT,
2% SDS, 0.1% bromophenol blue, 10% glycerol) were heated at 1008C for 5 min
and analyzed on an SDS–14% polyacrylamide gel.
RNA transfection. PV RNA (type 1 Mahoney) was isolated from infected
HeLa cells as described elsewhere (14). Lipofectin-mediated RNA transfection
of HeLa monolayer cells was performed essentially as described previously (13).
In vivo labeling and immunoprecipitation. In vivo labeling of proteins after
RNA transfection and immunoprecipitation of the PV capsid proteins were done
as described previously (13, 45).
RESULTS
I-RNA interacts with human La autoantigen. Previous stud-
ies from our laboratory have shown that I-RNA specifically
interacts with a 52-kDa HeLa cell protein and that this inter-
action may play an important role in translation inhibition of
IRES-mediated translation by I-RNA (13). Because a 52-kDa
protein has previously been shown to interact with a specific
region of PV 59 UTR (nt 559 to 624) and this protein has been
identified as the human La autoantigen (36), we determined
whether the 52-kDa I-RNA-binding protein is similar to La
protein. As shown in Fig. 1A, a gel-retarded complex (complex
C) containing labeled I-RNA and HeLa cell proteins was su-
pershifted by an antibody to the human La protein (Fig. 1A,
lanes 3 and 4). A similar complex formed with labeled I-RNA
and purified recombinant La protein (lane 5, complex C) can
also be supershifted with the anti-La antibody to the same
relative position as found with the HeLa cell extract. A second,
more slowly migrating complex was also observed with purified
La protein (lane 5), the majority of which could not be super-
shifted with the anti-La antibody (lane 6). This more slowly
migrating complex was previously detected by Meerovitch et
al. when purified La preparation was used for gel shift analysis
using PV 59 UTR nt 559 to 624 as the probe (36). The nature
of this complex is not known. These results suggest that com-
plex C formed by incubating labeled I-RNA and HeLa cell
extract contains La autoantigen. To confirm that complex C
indeed contains La protein, UV cross-linking studies were per-
formed with 32P-labeled I-RNA and 59 UTR (nt 559 to 624)
probes, using HeLa cell extract or purified La protein. UV
cross-linked complexes were then immunoprecipitated with
anti-La or nonimmune serum and analyzed by SDS-polyacryl-
amide gel electrophoresis. A 52-kDa UV cross-linked protein
was specifically immunoprecipitated by the anti-La antibody
when complexes were formed with the HeLa cell extract, using
either a labeled I-RNA or UTR probe (Fig. 1B, lanes 2 and 5).
This 52-kDa band comigrated with a UV cross-linked, anti-La-
immunoprecipitated complex formed by incubating purified La
protein with 32P-labeled I-RNA (lane 3) or 32P-labeled 59UTR
(lane 6). A prominent ;120-kDa complex seen in lanes 2 and
5 was not specific to La antibody, as it could also be detected
in lanes containing nonimmune serum (Fig. 1C, lanes 1 and 2).
The intensity of the 120-kDa complex varied greatly between
the two experiments (Fig. 1B and C), presumably because
different HeLa extracts were used in these experiments. These
results demonstrate that I-RNA interacts with the human La
autoantigen.
Inhibition of IRES-mediated translation by I-RNA is re-
versed by La antigen. PV inhibits cap-dependent translation of
host cell mRNAs by proteolytically cleaving the p220 compo-
nent of the cap-binding protein complex. Therefore, extracts
derived from virus-infected cells are active in cap-independent
IRES-mediated translation but not in cap-dependent transla-
tion (55). To determine whether I-RNA-induced inhibition of
IRES-mediated translation can be specifically rescued by ex-
ogenous addition of purified La protein, translation of p2CAT
RNA (59 UTR-CAT) was performed in virus-infected cell ex-
tracts. Translation of p2CAT RNA in PV-infected HeLa cell
extract in the presence of I-RNA was inhibited to 20% of that
of the control (Fig. 2, lanes 1 and 2). Significant stimulation
(1.5-fold) of viral 59 UTR-mediated translation was observed
when purified La protein was added to the infected cell extract
FIG. 1. The HeLa 52-kDa I-RNA-binding protein is identical to La autoantigen. (A) Gel shift. 32P-labeled I-RNA probe was incubated with 50 mg of HeLa S10
extract (lanes 3 and 4) or with 0.3 mg of purified La protein expressed from the recombinant La clone (lanes 5 and 6) in the presence (lanes 4 and 6) or absence (lanes
3 and 5) of antibody to La autoantigen. I-RNA–protein complexes (C) formed with HeLa S10 or purified La protein were supershifted (SC) with anti-La antibody. Lanes
1 and 2 are minus-probe and minus-extract controls, respectively. (B) 32P-labeled I-RNA (lanes 1 to 3) and 32P-labeled PV 59 UTR (nt 559 to 624) RNA (lanes 4 to
6) were UV cross-linked to HeLa S10 proteins (lanes 2 and 5) or purified La protein (lanes 3 and 6). After RNase digestion, protein-nucleotidyl complexes were
immunoprecipitated with an anti-La antibody and were analyzed on an SDS-polyacrylamide gel. The immunoprecipitated bands are indicated with arrowheads. Lane
M shows the migration of 14C-labeled protein markers (Gibco BRL) having approximate molecular masses of 14, 18, 29, 43, 68, and 97 kDa (from bottom to top). (C)
32P-labeled I-RNA was UV cross-linked to HeLa S10 proteins (lanes 1 and 2) or purified La protein (lanes 3 and 4) and then immunoprecipitated with either
nonimmune human serum (lanes 1 and 3) or the La antibody isolated from the patient serum (lanes 2 and 4). The immune serum-specific 32P-labeled proteins were
then analyzed by SDS-polyacrylamide gel electrophoresis followed by autoradiography.
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(Fig. 2; compare lane 5 with lane 1). This effect is probably due
to a limiting amount of La protein in virus-infected cells. In-
hibition of translation mediated by I-RNA (lane 2) can be
reversed by addition of purified La protein (lane 3) to approx-
imately 90% of the value for the control containing La protein
alone (lane 5). In the presence of a constant amount of I-RNA,
reversal of IRES-mediated translation by exogenously added
La was concentration dependent (data not shown). In contrast,
addition of an equivalent amount of BSA failed to restore
IRES-mediated translation (lane 4). A similar result was ob-
served when mock-infected extracts were used instead of virus-
infected cell extracts (data not shown). The higher-molecular-
weight band seen in translation reactions was not a translation
product, as it can also be detected in reactions lacking mRNA
(data not shown). Cap-dependent translation of CAT was not
stimulated by additions of La (data not shown).
Minimum sequences required for I-RNA activity. To deter-
mine I-RNA sequences required for inhibition of PV IRES-
mediated translation, a nested set of 15-nt-long deletions was
generated (I-1, I-2, I-3, and I-4; Fig. 3). Effects of these trun-
cated RNAs on in vitro translation programmed by p2CAT
RNA containing the PV 59 UTR were determined. As shown
in Fig. 4A, both I-1 and I-2 RNAs were still active in transla-
tion inhibition, although they were not as active as intact I-
RNA (compare lanes 2, 3, and 6 with lane 1). Deletion of nt 31
to 45 and 46 to 60 (I-3 and I-4) from I-RNA, however, almost
totally destroyed its ability to inhibit IRES-mediated transla-
tion (lanes 4 and 5). These results suggest that the 39-terminal
half of I-RNA contains major sequences necessary for inhibi-
tion of viral IRES-mediated translation. However, it should be
noted that sequences present within the first 15 (i.e., I-1) or the
next 15 (I-2) nt also play a role in inhibition, since these
mutants are not as active as intact I-RNA (lanes 2 and 3).
Further deletion analysis showed that a 25-nt-long fragment of
I-RNA (I-7 RNA, nt 26 to 50) was as active as I-RNA in viral
translation inhibition (Fig. 4B, lane 5). A similar deletion mu-
tant that contained an extra 10 nt at its 39 end (I-6 RNA, nt 26
to 60) was active but not as active as I-7 RNA (Fig. 4B, lane 4).
A fragment of I-RNA containing nt 1 to 25 (I-8 RNA), how-
ever, was totally inactive in translation inhibition (Fig. 4C, lane
2). Further deletion of I-7 RNA resulted in a smaller fragment
(I-9 RNA, nt 30 to 45) capable of inhibiting IRES-mediated
translation (Fig. 4C, lane 3). The ability of I-9 RNA to inhibit
translation (Fig. 4C, lane 3) is fully consistent with the inability
of I-3 RNA to arrest translation (Fig. 4A, lane 4), as I-3 RNA
lacks nt 31 to 45 (Fig. 3). None of these mutant I-RNAs were
able to inhibit cap-dependent translation of pCAT RNA (Fig.
FIG. 2. Purified La protein can rescue I-RNA-mediated inhibition of trans-
lation programmed by the PV 59 UTR. p2CAT RNA (2 mg) was translated in
vitro in PV-infected HeLa cell lysate as described in Materials and Methods.
Thirty micrograms of HeLa lysate was preincubated on ice for 30 min either
alone (lane 1) or in the presence of 1 mg of I-RNA (lane 2) or 1 mg of I-RNA
together with 1.5 mg of La (lane 3) or 1 mg of I-RNA mixed with 1.5 mg of BSA
(lane 4) or only with 1.5 mg of purified La protein (lane 5). The translation
products were analyzed by SDS–14% polyacrylamide gel electrophoresis. The
position of the CAT gene product is indicated on the right.
FIG. 3. I-RNA deletions. The diagram shows the I-RNA deletion mutant constructs. The nucleotide positions of the mutation sites are indicated for each mutant.
The names of the mutants are given at the left. The numbers in parentheses indicate percentages of translation inhibition by mutant I-RNAs compared with wild-type
I-RNA (100%), calculated by averaging results of three independent experiments, including those in Fig. 4.
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4D and data not shown). Quantitation of translation inhibition
by various deletion mutants of I-RNA is shown in Fig. 3.
I-7 and I-9 RNAs inhibit internal initiation of translation.
To determine whether the truncated I-RNAs are capable of
inhibiting internal initiation of translation, their effects on
translation from a bicistronic construct were determined. A
bicistronic construct containing CAT and luciferase genes
flanked by the PV 59 UTR was used in this experiment. The
initiation of cap-independent translation occurring internally
from the PV 59UTR would result in the synthesis of luciferase,
whereas cap-dependent translation would normally produce
the CAT protein. In uninfected HeLa cell extracts, translation
from the capped bicistronic message produced both CAT and
luciferase proteins in separate experiments using different cell
extracts (Fig. 5A, lane 1; Fig. 5B, lane 1). Addition of full-
length I-RNA preferentially inhibited synthesis of luciferase
but not that of CAT (Fig. 5A, lane 3). The 25-nt-long I-7 RNA
almost totally (.90%) inhibited production of luciferase (lane
2). CAT synthesis, however, was stimulated approximately 3.5-
fold in reactions containing I-7 RNA compared with the con-
trol (lane 2). No inhibition of luciferase synthesis was apparent
with the mutant I-4 RNA (lane 4). Synthesis of CAT protein
was also stimulated 3.7-fold by I-4 RNA (lane 4). Similar re-
sults were obtained with I-9 and I-8 RNAs. The 16-nt-long I-9
RNA inhibited luciferase synthesis significantly compared with
the control (Fig. 5B, lanes 1 and 2). Although 20% inhibition
of CAT production was observed in presence of I-9 RNA,
luciferase synthesis was inhibited almost 85% over the control
(lane 2). In contrast, I-8 RNA did not significantly inhibit
synthesis of either luciferase or CAT (lane 3). These results
suggest that I-7 and I-9 RNAs, but not I-4 and I-8 RNAs,
preferentially inhibit internal initiation of translation pro-
grammed by the PV 59 UTR. Although not shown here, all
deletion mutants shown in Fig. 3 showed similar activities of
translation inhibition irrespective of whether mono- or bicis-
tronic mRNAs were used (data not shown).
I-7 and I-9 RNAs inhibit translation of PV RNA in vivo. To
determine whether mutant I-RNAs inhibit translation of PV
RNA in vivo, PV RNA was transfected (by using liposome)
into HeLa cells singly or together with purified I-7, I-9, I-4, I-8,
and I-RNAs. Proteins were labeled with [35S]methionine, and
the synthesis of viral proteins was monitored by immunopre-
cipitation of viral capsid proteins from cell extracts by anticap-
sid antisera. As shown in Fig. 6A, no capsid protein could be
precipitated from mock-transfected cells (lane 1). Upon trans-
fection of cells with PV RNA alone, synthesis of capsid pro-
teins was clearly detected (Fig. 6A, lane 2; Fig. 6B, lane 1).
Cotransfection of I-7 RNA (Fig. 6A, lane 3) or I-RNA (Fig.
6A, lane 4; Fig. 6B, lane 5) with PV RNA resulted in over 90%
inhibition of capsid protein synthesis. Activity of I-9 RNA was
approximately 50% of that observed with I-7 or I-RNA (Fig.
6B, lane 4). Higher concentrations of I-9 RNA, however, in-
hibited viral protein synthesis to the extent seen with I-7 RNA
(data not shown). As expected, I-8 RNA and I-4 RNA were
unable to inhibit translation of viral proteins (Fig. 6B, lanes 2
and 3). It should be noted that similar amounts of intracellular
PV RNAs were detected in both cells transfected with PV
RNA alone and those transfected with a mixture of PV RNA
and I-7 or I-9 RNA at early time points, suggesting that the
stability of input PV RNA is not altered significantly in cells
containing I-RNA or its derivatives (data not shown).
Protein binding of I-RNA mutants examined by UV cross-
linking. Results presented in Fig. 4 to 6 demonstrated differ-
ences in activities of various I-RNA mutants in inhibiting
IRES-mediated translation. While I-7 and I-9 RNAs were ca-
pable of inhibiting PV IRES-mediated translation, I-4 and I-8
RNAs were almost totally inactive as translation inhibitors. To
determine whether similar or different proteins were bound by
these RNAs, various labeled RNA probes were incubated with
HeLa proteins, and protein-RNA complexes were examined by
UV cross-linking following RNase digestion.
FIG. 4. Minimum I-RNA sequences necessary for inhibition of in vitro translation in HeLa lysates programmed by the 59 UTR of PV RNA. The effects of different
I-RNA deletion mutants on in vitro translation of pG3CAT and p2CAT RNAs in HeLa lysates were determined. In vitro translations were performed with
approximately 2 mg of either uncapped p2CAT RNA (A to C) or capped pG3CAT RNA (D) in the absence (lanes C of all the panels) or in the presence of 2 mg of
I-RNA deletion mutant as indicated. The position of the CAT protein is indicated at the left.
FIG. 5. Effects of I-RNA deletions on internal initiation of translation in
vitro. A bicistronic construct containing CAT and luciferase genes flanked by the
PV type 2 59 UTR was translated in vitro in HeLa cell lysates in the absence
(lanes C) or presence of 2 mg of either I-RNA (A, lane 3) or the I-RNA deletion
indicated above each lane. Products were analyzed on an SDS–14% polyacryl-
amide gel. Arrowheads indicate positions of the luciferase (LUC) and CAT gene
products.
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Two sources of HeLa proteins were used for these experi-
ments, S10 (Fig. 7A, lanes 1 to 6) and RSW (lanes 7 to 12).
When full-length labeled I-RNA was incubated with HeLa S10
extract, two major bands with approximate molecular masses
of 52 and 110 kDa were detected in addition to minor bands at
100, 70, 48, and 46 kDa (lane 2). When RSW proteins were
used, the profile of protein-nucleotidyl complexes was signifi-
cantly different from that with S10 (lane 8). First, the 110-kDa
band was present in very low amounts in reactions containing
RSW. Second, the 52-kDa protein was present as a doublet of
54 to 52 kDa and in relatively lower amounts than in S10.
Third, new bands at approximately 80 and 37 kDa were appar-
ent in RSW-containing reactions. In contrast to full-length
I-RNA, when labeled truncated I-RNAs were used in UV
cross-linking experiments, the protein-nucleotidyl profiles for
each RNA were remarkably similar between S10 (lanes 3 to 6)
and RSW (lanes 9 to 12). While I-4 and I-8 RNAs bound
mainly polypeptides of 70, 52, 48, 46, and 37 kDa, I-7 and I-9
RNAs interacted with a new band at 80 kDa (compare lanes 3
and 4 with lanes 5 and 6). The 80-kDa band was more pro-
nounced with I-7 RNA. Additionally, the 70-kDa polypeptide
bound by I-4 and I-8 RNAs was not detected with I-7 and I-9
RNAs. Another very high molecular weight polypeptide (run-
ning faster than the 220-kDa marker) was present only in
reactions containing I-4 and I-8 RNAs (lanes 3 and 4). Simi-
larly, in experiments using RSW, the 100-kDa polypeptide was
preferentially bound by I-7 and I-9 RNAs (lanes 11 and 12).
The autoradiogram shown in Fig. 7A was overexposed pur-
posely to detect even minor protein-nucleotidyl complexes.
In competition experiments, it was observed that unlabeled
I-7 and I-4 RNAs successfully competed with all major protein
bands bound by labeled I-7 and I-4 RNA probes (Fig. 7B). For
example, all three polypeptides, 80, 52, and 37 kDa, complexed
to I-7 RNA (Fig. 7B, lane 2) were diminished with unlabeled
I-7 and I-4 RNAs (lanes 3 and 4) but not with a nonspecific
RNA (lane 5). Similarly, with labeled I-4 RNA, the 70-, 52-,
and 37-kDa bands were diminished with unlabeled I-7 and I-4
RNAs (lanes 8 and 9) but not with a nonspecific competitor
(lane 10). A higher molecular weight polypeptide was nonspe-
cifically bound to I-4 RNA, as it could be totally abolished with
a nonspecific competitor (compare lanes 7 and 10). These
results demonstrate that while the active I-7 and inactive I-4
RNAs bind the same two polypeptides (52 and 37 kDa), these
two truncated I-RNAs differ from each other in binding at least
one polypeptide; while I-7 RNA binds the 80-kDa polypeptide,
I-4 RNA binds a 70-kDa polypeptide.
FIG. 6. Inhibition of PV translation in vivo by the I-RNA deletion mutants.
HeLa monolayer cells were transfected with PV RNA alone (A, lane 2; B, lane
1) or viral RNA together with 4 mg of either intact I-RNA (A, lane 4; B, lane 5)
or I-7 RNA (A, lane 3), I-4 RNA (B, lane 2), I-8 RNA (B, lane 3), or I-9 RNA
(B, lane 4). After transfection, cells were labeled with [35S]methionine, and in
vivo-labeled proteins were immunoprecipitated with anticapsid antibody and
analyzed on an SDS–14% polyacrylamide gel. Positions of the PV capsid proteins
are indicated by arrowheads. In panels A and B, 1.5 and 1 mg, respectively, of PV
RNAs were used for transfection. The total RNA concentration in each trans-
fection was adjusted to 20 mg by adding carrier tRNA. Lanes M show the
migration of 14C-labeled protein markers (Gibco BRL) having approximate
molecular masses of 14, 18, 29, 43, 68, 97 kDa (from bottom to top).
FIG. 7. Cellular proteins that interact with full-length and deleted I-RNAs. (A) UV cross-linking of 32P-labeled I-RNA or truncated I-RNAs with HeLa S10 or RSW
proteins was performed as described in Materials and Methods. Numbers at the left refer to the approximate molecular masses (in kilodaltons) of the proteins that
cross-link to the labeled RNA probes. Lane M shows the migration of 14C-labeled rainbow protein markers (Amersham) with molecular masses of 30, 46, 66, 97, and
220 kDa (from bottom to top). Lanes 1 and 7 contained the probes but no S10 and RSW, respectively. The labeled probes used for UV cross-linking are shown above
the lanes. (B) Competition UV cross-linking studies with 32P-labeled I-7 RNA (lanes 1 to 5), I-4 RNA (lanes 6 to 10), and I-RNA (lanes 11 and 12) probes were
performed with 10 mg of HeLa RSW in the presence (lanes 3 to 5 and 8 to 10) or absence (lanes 1, 2, 6, 7, 11, and 12) of unlabeled competitor RNAs. A 100-fold molar
excess of each unlabeled competitor RNA was used. Lanes 3, 4, and 5 contained unlabeled I-7 RNA, I-4 RNA, and nonspecific RNA, respectively. Lanes 8, 9, and 10
contained unlabeled I-4, I-7, and nonspecific RNA, respectively. Lanes 1, 6, and 11 contained labeled probes but no RSW proteins. (C) UV cross-linking studies were
performed with 32P-labeled 59 UTR (13) (lanes 2 and 3) and 32P-labeled I-RNA (lanes 4 to 6). Ten micrograms of HeLa RSW was incubated with 32P-UTR (lane 3)
and 32P-I-RNA in the absence (lane 4) or presence of a 50-fold molar excess of unlabeled UTR (lane 5) or a nonspecific RNA (lane 6). Lane 2 had 32P-UTR but no
protein. Lane 1 shows the migration of protein markers. The dots at the left show migration of 94-, 67-, 43-, and 29-kDa marker proteins (from top to bottom).
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To determine whether the PV 59 UTR binds polypeptides
similar to those observed with I-RNA, UV cross-linking studies
were performed with HeLa RSW and labeled 59 UTR or I-
RNA. As can be seen in Fig. 7C, both UTR (lane 3) and
I-RNA (lane 4) bound polypeptides with apparent molecular
masses of 80, 70, 52, 43, and 37 kDa. A more slowly migrating
band at approximately 100 kDa was observed when I-RNA was
used as the probe (lane 4). That the polypeptides bound by
UTR and I-RNA were similar was confirmed by a competition
experiment using labeled I-RNA and unlabeled 59 UTR (lanes
5 and 6). Almost all polypeptides bound to labeled I-RNA
could be abolished by inclusion of unlabeled UTR during the
assay (lane 5). However, a similar amount of a nonspecific
RNA was totally ineffective in inhibiting cross-linking of I-
RNA to these polypeptides (lane 6). These results suggest that
similar polypeptides (80, 70, 52, and 37 kDa) bind to both
I-RNA and the viral 59 UTR. Although the 100-kDa polypep-
tide did not bind to labeled UTR (lane 3), binding of this
polypeptide to labeled I-RNA was inhibited by unlabeled UTR
(lane 5) for an unknown reason.
In an attempt to determine whether I-RNA deletion mu-
tants demonstrate different La binding activities in an assay
other than UV cross-linking, various labeled I-RNA deletion
mutants were incubated with purified La and protein-RNA
complexes were analyzed by a gel shift assay. No significant
difference in La binding by I-4, I-8, I-7, and I-9 RNAs was
apparent in this experiment (data not shown). Thus, there is no
direct correlation between the activities of I-RNA deletion
mutants and their abilities to bind La.
DISCUSSION
We have shown here that a small yeast RNA (I-RNA) which
selectively blocks PV IRES-mediated translation physically in-
teracts with the human La autoantigen. Both immunoprecipi-
tation following UV cross-linking of the recombinant La pro-
tein to I-RNA and the ability to supershift the La–I-RNA
complex with an anti-La antibody attest to this fact (Fig. 1).
That binding of La to I-RNA may be relevant is indicated by
the fact that purified recombinant La protein is able to restore
PV IRES-mediated translation in the presence of the inhibitor
RNA (Fig. 2). Our results are consistent with a previously
published report which demonstrated the ability of La to cor-
rect aberrant translation of PV RNA in reticulocyte lysate,
which is naturally deficient in La protein (36). Using deletion
analysis, we also identified regions of I-RNA as small as 16 nt
which retain the ability to inhibit PV IRES-mediated transla-
tion both in vitro and in vivo (Fig. 4 to 6). Finally, a comparison
of protein binding by active and inactive truncated I-RNA
mutants suggests that in addition to the La (p52) protein, three
other polypeptides with apparent molecular masses of 80, 70,
and 37 kDa may influence the translation-inhibitory activity of
I-RNA (Fig. 7).
It is clear from the deletion analysis that the minimum se-
quence required to inhibit PV IRES-mediated translation ap-
pears to reside between nt 30 and 45. This notion is supported
by two observations. First, a deletion mutant (I-3 RNA) which
contains the entire I-RNA sequence except nt 31 to 45 is totally
inactive in inhibiting viral IRES-mediated translation. Second,
a truncated I-RNA (nt 30 to 45; I-9 RNA) retains a consider-
able amount of translation-inhibitory activity (Fig. 4C). How-
ever, a 25-nt-long truncated RNA (I-7 RNA) containing the
I-9 RNA sequence appears to be more active, particularly in
vivo (Fig. 6A). The shorter I-9 RNA was only 50% as active as
I-RNA in vivo. It is worth mentioning in this context that both
I-7 and I-9 RNAs can assume secondary structures having
stem-loops (data not shown). Clearly, because of its smaller
size, I-9 RNA is much less stable than I-RNA, which may affect
its stability inside a cell. It will be interesting to determine
whether a thio derivative of I-9 RNA is more active than the
normal I-9 RNA. The structure(s) of I-RNA or its truncated
derivatives may be important in IRES-mediated translation
inhibition. The fact that addition of an extra 10 nt to the 39 end
of I-7 RNA (nt 26 to 50) significantly reduces the translation-
inhibitory activity of the resultant construct (I-6 RNA, nt 26 to
60) may be indicative of alteration of structure of this RNA
(Fig. 3 and 4B). Similarly, addition of another 5 nt to the 59 end
of I-6 RNA drastically reduces the ability of the resultant
construct (I-5 RNA, nt 20 to 60) to inhibit translation (Fig.
4B).
The fact that I-7 and I-9 RNAs inhibit viral IRES-mediated
translation but I-4 and I-8 do not (Fig. 4 to 6) prompted us to
examine protein binding to these RNAs. UV cross-linking
studies using various labeled RNAs and competition experi-
ments demonstrated that both I-7 and I-4 RNAs bound two
common polypeptides, of 52 and 37 kDa. However, these two
RNAs differed from each other in that I-7 RNA bound an
80-kDa polypeptide whereas I-4 RNA interacted with a 70-
kDa polypeptide. Many possible explanations can be thought
of regarding the difference in protein binding of I-7 and I-4
RNAs. It is possible that in addition to 52- and 37-kDa
polypeptides, binding of the 80-kDa protein to the viral 59
UTR is important for internal initiation to occur and that I-7
RNA directly competes with the 59 UTR in binding these
polypeptides. A recent study by Meyer et al. using UV cross-
linking indicates the importance of a 80-kDa protein in IRES-
mediated translation of FMDV (37). This 80-kDa protein has
been identified as initiation factor eIF-4B. The results pre-
sented by Meyer et al. suggest that additional protein factors
contribute to this interaction of eIF-4B with the FMDV IRES
(37). It is possible that binding of eIF-4B to the viral IRES
requires La and 37-kDa polypeptides and or other polypep-
tides. I-7 RNA may interfere with IRES-mediated translation
by binding these polypeptides (Fig. 7). Despite their interac-
tions with 52- and 37-kDa polypeptides, I-4 and I-8 RNAs may
not efficiently inhibit translation because of their inability to
interact with the 80-kDa polypeptide. It appears from our
results (Fig. 7) that binding of the 70-kDa protein to I-4 and I-8
RNAs inhibit their ability to interfere with IRES-mediated
translation. It is possible that binding of the 70-kDa polypep-
tide to I-4 and I-8 RNAs prevents these RNAs from interacting
with the 80-kDa polypeptide. Alternatively, these RNAs may
lack the binding site (or structure) for the 80-kDa polypeptide.
Future studies will be directed toward identifying the 80- and
70-kDa polypeptides, which may lead to a better understanding
of the roles of these polypeptides in IRES-mediated transla-
tion.
Despite its inability to bind the 80-kDa polypeptide, I-4
RNA, when used as a competitor, prevents binding of the
80-kDa protein to a labeled I-7 RNA probe (Fig. 7B). Because
both I-7 and I-4 RNAs bind La and 37-kDa polypeptides, this
result suggests that the interaction of the 80-kDa polypeptide
with I-7 RNA may be primarily through La and/or 37-kDa
polypeptides, although the polypeptide (80 kDa) must some-
how touch the RNA because it can be cross-linked (albeit
weakly) to the I-7 RNA. In contrast, interaction of the 70-kDa
protein to I-4 RNA appears relatively strong, suggesting direct
interaction with I-4 RNA (Fig. 7). Because I-7 and I-9 RNAs
do not bind the 70-kDa polypeptide but I-8 and I-4 RNAs do,
it appears that at least the 59-terminal 25 nt of I-RNA may be
important in 70-kDa protein binding in the form of either a
sequence or structure or both. Consistent with this idea is the
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fact that I-3 RNA also binds the 70-kDa polypeptide (data not
shown).
The normal function of I-RNA in the yeast S. cerevisiae is
not known. Very recently, Christopher and Wolin reported
identification of a human La-homologous protein in S. cerevi-
siae (11). It would be interesting to determine whether the
yeast La protein interacts with I-RNA. This may lead to a
better understanding of the function of I-RNA in S. cerevisiae.
Indeed, some evidence of IRES-mediated translation in S.
cerevisiae has recently been reported (23, 56). Our future stud-
ies will be directed toward more defined mutational analysis of
I-RNA function and protein binding. These studies along with
determination of I-RNA structure should help us delineate the
mechanism of IRES-mediated initiation of translation in eu-
karyotes.
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